Skip to Content

尊敬的客户:

目前国际形势复杂多变,关税政策尚不明朗,这可能对我们的产品价格产生一定影响。在此情况下,我们希望就订单事宜与您进行友好沟通。

基于当前的不确定性,如果您选择在此期间下单,我们将保留根据实际情况调整价格的权利。同时,我们也理解市场变化可能给您带来的困扰,因此如果在订单实际发货前因关税政策变动导致价格出现较大波动,默克将与您进行协商讨论并视情况对订单进行调整或取消。

Merck
CN
All Photos(1)

Key Documents

Safety Information

11018AST

Supelco

Astec® CHIROBIOTIC® V Chiral (5 μm) HPLC Columns

L × I.D. 10 cm × 2.1 mm, HPLC Column

Sign Into View Organizational & Contract Pricing

Select a Size

5 G
¥897.27
25 G
¥1,463.25

¥897.27


Available to ship on2025年4月25日Details



Select a Size

Change View
5 G
¥897.27
25 G
¥1,463.25

About This Item

UNSPSC Code:
41115700
eCl@ss:
32110501
NACRES:
SB.52

¥897.27


Available to ship on2025年4月25日Details


Product Name

Astec® CHIROBIOTIC® V Chiral HPLC Column, 5 μm particle size, L × I.D. 10 cm × 2.1 mm

material

stainless steel column

Quality Level

Agency

suitable for USP L88

description

HPLC Column

product line

Astec®

packaging

pkg of 1 ea

manufacturer/tradename

Astec®

parameter

0-45 °C temperature
241 bar pressure (3500 psi)

technique(s)

HPLC: suitable
LC/MS: suitable

Looking for similar products? Visit Product Comparison Guide

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
FHIFINROEHIFIPROEHIFIPNRO
technique(s)

PCR: suitable

technique(s)

PCR: suitable

technique(s)

PCR: suitable

technique(s)

PCR: suitable

usage

sufficient for ≤1,000 reactions (03553361001)

usage

sufficient for ≤200 reactions (04738292001), sufficient for ≤50 reactions (04738284001)

usage

sufficient for ≤2,500 reactions (03300234001), sufficient for 2500 reactions, sufficient for ≤500 reactions (03300226001), sufficient for 500 reactions

usage

sufficient for ≤125 reactions (04743725001), sufficient for ≤500 reactions (04743733001)

feature

High Fidelity PCR

feature

-

feature

High Fidelity PCR, dNTPs included: no, hotstart: no

feature

High Fidelity PCR, dNTPs included, hotstart: no

packaging

pkg of 2,500 U (03553361001 [10 x 250 U])

packaging

pkg of 125 U (04738284001), pkg of 500 U (04738292001 [2 x 250 U])

packaging

pkg of 2,500 U (03300234001 [10x250 U]), pkg of 500 U (03300226001 [2x250 U])

packaging

pkg of 125 U (04743725001), pkg of 500 U (04743733001 [2x250 U])

manufacturer/tradename

Roche

manufacturer/tradename

Roche

manufacturer/tradename

Roche

manufacturer/tradename

Roche

concentration

5 unit/μL

concentration

-

concentration

-

concentration

50 U/mL (working concentration)

General description

Neutral molecules, amides, acids, esters and amines show considerable enantioselectivity on these vancomycin-based CSPs. A wide variety of secondary and tertiary amines have been separated on the CHIROBIOTIC® V in the polar ionic mode. The CHIROBIOTIC® V has demonstrated many of the separation characteristics of protein-based stationary phases, but with exceptional stability and much higher sample capacity. Some chiral analytes have been resolved that have not been reported separated on any other chiral stationary phase. CHIROBIOTIC® V and V2 differ in their bonding chemistry the pore size of the support particle, giving them different selectivity and preparative capacity.

  • Bonded phase: Vancomycin
  • Operating pH range: 3.5 - 7.0
  • Particle diameter: 5, 10 or 16 μm
  • Pore size: 100 Å (CHIROBIOTIC® V) or 200 Å (CHIROBIOTIC® V2)

Recommended products

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Legal Information

Astec is a registered trademark of Merck KGaA, Darmstadt, Germany
CHIROBIOTIC is a registered trademark of Sigma-Aldrich Co. LLC

Regulatory Information

新产品

  • Choose from one of the most recent versions:

    Certificates of Analysis (COA)

    Lot/Batch Number

    Don't see the Right Version?

    If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Chiral stability-indicating HPLC method for analysis of arotinolol in pharmaceutical formulation and human plasma
    Sultan, Maha A., et al.
    Arabian Journal of Chemistry, 3 (3), 147-153 (2010)
    Ana R Ribeiro et al.
    Chemosphere, 95, 589-596 (2013-11-05)
    Microbial degradation is the most important process to remove organic pollutants in Waste Water Treatment Plants. Regarding chiral compounds this process is normally enantioselective and needs the suitable analytical methodology to follow the removal of both enantiomers in an accurate
    Hisham Hashem et al.
    Journal of chromatography. A, 1218(38), 6727-6731 (2011-08-23)
    In this study, a method for enantioseparation of terbutaline and salbutamol was established using Chirobiotic V column as a stationary phase. Polar ionic mode applying mobile phase containing ammonium nitrate in 100% ethanol, pH 5.1 was found to give the
    Enantiomeric separation of mirtazapine and its metabolite in rat plasma by reverse polar ionic liquid chromatography using fluorescence and polarimetric detectors connected in series
    Rao, R. Nageswara, et al.
    Journal of Chromatography. B, Biomedical Sciences and Applications, 879 (21), 1911-1916 (2011)
    Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography
    Kosel, M., et al.
    Journal of Chromatography. B, Biomedical Applications, 719 (1-2), 234-238 (1998)

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service